ketotifen has been researched along with Leukopenia in 1 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Leukopenia: A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costa, JJ | 1 |
| Harris, AG | 1 |
| Delano, FA | 1 |
| Zweifach, BW | 1 |
| Schmid-Schönbein, GW | 1 |
1 other study available for ketotifen and Leukopenia
| Article | Year |
|---|---|
Mast cell degranulation and parenchymal cell injury in the rat mesentery.
Topics: Animals; Cell Degranulation; Endothelium; Ketotifen; Leukopenia; Male; Mast Cells; Mesentery; p-Meth | 1999 |